Impact of rheumatoid arthritis in Turkey: a questionnaire study

Basit Öğe Kaydı
dc.authoridGul, Ahmet/0000-0001-8219-3720
dc.authoridYazıcı, Ayten/0000-0003-2167-4509
dc.authoridinanç, murat/0000-0002-6376-5583
dc.authoridAkkoc, Nurullah/0000-0002-3718-171X
dc.authoridHamuryudan, Vedat/0000-0001-6625-1652
dc.authoridYUCEL, A. EFTAL/0000-0002-4860-9072
dc.authorwosidYUCEL, A. EFTAL/F-8858-2011
dc.authorwosidÖztürk, Mehmet/JFJ-3399-2023
dc.authorwosidKeser, Gokhan/I-4282-2019
dc.authorwosidDireskeneli, Haner/AAS-5508-2020
dc.authorwosidGul, Ahmet/AAT-7787-2020
dc.authorwosidOzdogan, Huri/L-3636-2019
dc.authorwosidCefle, Ayse/AAT-3653-2020
dc.contributor.authorDireskeneli, H.
dc.contributor.authorAkkoc, N.
dc.contributor.authorBes, C.
dc.contributor.authorCakir, N.
dc.contributor.authorCefle, A.
dc.contributor.authorCobankara, V.
dc.contributor.authorDalkilic, E.
dc.date.accessioned2024-06-12T11:13:40Z
dc.date.available2024-06-12T11:13:40Z
dc.date.issued2014
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjective Unmet needs of rheumatoid arthritis (RA) patients regarding physician/patient communication, treatment preferences and quality of life issues were investigated in a Turkish survey study. Methods The study was conducted with the contribution of 33 rheumatologists, and included 519 RA patients. The study population included patients who had been on biologic therapy for >6 months and were still receiving biologic therapy (BT group), and those who were biologic naive, but found eligible for biologic treatment (NBT group). Of the RA patients, 35.5% initially had a visit to an internal disease specialist, 25.5% to a physical therapy and rehabilitation specialist, and 12.2% to a rheumatology specialist for their RA complaints. The diagnosis of RA was made by a rheumatologist in 48.2% of patients. Results The majority of RA patients (86.3%) visit their doctor within 15-week intervals. Most of the physician-patient communication focused on disease symptoms (99.0%) and impact of the disease on quality of life (61.8%). The proportion of RA patients who perceived their health status as good/very good/excellent was higher in the BT group than in the NBT group (74.3% vs. 51.5%, p<0.001). However, of those RA patients in the NBT group, only 24.8% have been recommended to start a biologic treatment by their doctors. With respect to dose frequency options, once-monthly injections were preferred (80%) to a bi-weekly injection schedule (8%). Conclusion In conclusion, RA patients receiving biologic therapy reported higher rates of improved symptoms and better quality of life and seemed to be more satisfied with their treatment in our study.en_US
dc.description.sponsorshipMerck Sharpe-Dohme Turkey, Merck & Co., Inc., Whitehouse Station, NJ, USAen_US
dc.description.sponsorshipThe survey and manuscript was sponsored by Merck Sharpe-Dohme Turkey, a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ, USA. The Investigators of the survey have received honoraria from MSD Turkey. No payments were made to authors for the writing of this manuscript.en_US
dc.identifier.endpage483en_US
dc.identifier.issn0392-856X
dc.identifier.issue4en_US
dc.identifier.pmid24960289en_US
dc.identifier.scopus2-s2.0-84904903828en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage477en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/23643
dc.identifier.volume32en_US
dc.identifier.wosWOS:000341171000006en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherClinical & Exper Rheumatologyen_US
dc.relation.ispartofClinical And Experimental Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectRheumatoid Arthritisen_US
dc.subjectQuality Of Lifeen_US
dc.subjectPatient Surveyen_US
dc.subjectTreatment Algorithmen_US
dc.subjectTherapyen_US
dc.subjectBiologicsen_US
dc.subjectOutcomesen_US
dc.subjectRegistryen_US
dc.subjectCareen_US
dc.titleImpact of rheumatoid arthritis in Turkey: a questionnaire studyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu